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Laparoscopic holecystectomy: Are patients with biliary pancreafitis at 
increased operative risk? 
Ammori B J, D Davides. A Vezokis, Larvm M, McMahon MJ 
Leeds Institute for Minimally Invasive Therapy, The General Infirmary, Leeds, LrK 
Introduction: Previous reports oflaparoscopic cholecyslcclomy (LC) m 
patients with binaq, pancreatitis suggested increased operative difficulty, high rates 
of conversion, longer postoperative hospital stay, and greater morbidity and 
mortality. Aims: To compare operative risk in patients undergoing LC for binary 
pancreatitis with those undergoing LC for other causes. Material and Methods: 
Between 1990 and 1997, g92 consecutive patients underwent LC, in keeping with a 
policy of"LC for all patients". Data were collected prospectively. LC was 
performed for binary pancreatitis in 63 patients (Group 1) and for other causes in 
829 patients (Group If). Results: Patients with binary pancreatitis were significantly 
older (median age 57 vs 50 years,/7=0.009), with greater co-morbidity (ASA Ill/IV 
24% vs I I%, p<0.02) included more males (4 1% vs 22%,/7<0.0 I ) and 
experienced a shorter symptom duration (median 5 vs 12 months, p=O.008). The 
groups were comparable with respect o the frequency of previous abdominal 
surgery, acute inflammation of the gallbladder, the frequency of bile duct calculi 
detected at intraoperative cholangiography (8% vs 6%) and urgent or elective 
operation. Moderate to severe adhesions were significantly more frequent after 
binary pancreatitis (46% vs 29%, p<O.05). No significant differences were observed 
between the two groups with respect o intraoperative (1.5% Group I vs 3.5% 
Group 1I) or postoperative complications (I 0% vs 8%), conversion rate (0 vs 2.7%) 
or duration of operation (median 92 vs 85 minutes). Conclusion: Despite increased 
age and co-morbidity and more frequent adhesions, our data showed no evidence 
that intraoperative or postoperative complications were more frequent in patients 
with binary pancreatitis than other patients undergoing LC. 
Enteral nutrition does not modify the early inflammatory response in acute 
pancreafitis. 
J j  Powell, G Hill, S Storey, J Murchison, K Fearon, J Ross & AK Sirtwardena. 
University Department of Surgery, Royal Infmnary of Edinburgh. 
Introduction Several studies report a benefit from early enteral nutrition (EEN) 
in acute pancreatitis. Although FEN is thought to reduce the early inflammatory 
response there is little evidence to support his paradigm m acute pancreatitis. We 
report an interim analysis ofa randomised controlled trial of EEN in severe acute 
pancreatitis, focusing on markers of the inflammatory esponse. 
Methods Patients with predicted severe acute pancreatitis were randomised 
to receive EEN or conventional treatment alone. The inflammatory response was 
quantified using measurements of protein serum interleukin 6 ([L6), soluble tumour 
necrosis factor receptor I (sTNFR) and C-reactive (CRP). Value are mean 
(standard error of the mean). 
Results 
Enteral nutrition Admission 
a=13 Day 2 
Day 4 
Conventional Admission 
n=14 Day 2 
Day 4 
Amd)s=s orvataano: (cntearal ~ cnn~ 
11..6 pg/nd 
266 (67) 
143 (65) 
64 (30) 
732 (377) . 
358 (236) 
127 (63) 
p = .281 
J sTNFR pg/mL 
301 s (.370) 
29o8 (266) 
2930 4267) , 
2459 (228) 
2626 (313) 
2602 (338) 
p = .559 
CRP mg/L 
17[(34) 
. 232 (30) 
I SO (25) 
23S (36) 
273 (29) 
213 (30) 
p = 624 
Conclusions Our results demonstrate hat EEN does not modify the early 
inflammatory response in severe acute pancreatitis. 
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Antibiotic use during the study of lexipafant in severe acute pancreatitis 
Pearce NW and Johnson CD. 
University Surgical Unit Southampton 
290 patients participated ina multi-centre, double-blind, randomised placebo 
controlled, parallel group study of Lexipafant in severe acute pancreatitis. 
Antibiotic use was recorded prospectively during the study and was similar in both 
the l.,r and placebo groups (95/148 and 99/138 respectively) of whom most 
were o~ antibiotics at recruitment (71/95 and 75/99). The majority received a
cephalosporm (76195 and 78/99). Patients were divided into three groups:- patients 
taking antibiotics at tecnfitment were termed the "'early" group, patients tarting 
antibiotics later were called the "delayed" group and thirdly the "no antibiotic" 
group. There were more local complications in the "delayed" group (16/48, 33*/,) 
than in the "early" (38/I 46, 26%, n.s.) or "no antibiotic" groups (10/92, 11%, gz 
p<0.01). Patients with a local complication were more likely to develop local sepsis 
in the "delayed" (9/16, 56%, Z 2 p<0.O01) or "no antibiotic" groups (4/10, 40%, X 2 
p<0.05) than in the "early" group (5/38, 13%)- Patients with necrosis were less 
likely to develop local infection in the "early" group than in the combined "delayed" 
and "no antibiotic" groups (5/27 v 13/25 g: p<O.01). Patients with sepsis were less 
likely to die if they were in the "early" antibiotic group Cm if they were in the 
combined "delayed" or "no antibiotic" groups (3/8 v 8/9 p<O.05 Fisher's exact test). 
Patients with predicted severe acute pancreatitis receiving early antibiotics are less 
likely to develop septic local complications and are less likely to die from septic 
complications than patients receiving delayed or no antibiotic treatment. 
Investigation o r the IL-I gene cluster and its association with acute paucreatitis 
A. M. Smithies. 1(+ Sargen, A, G, Demame, A. N. Kingsnorth 
Departments Molecular Medicine and Surgery, Plymouth Postgraduate Medical 
School, Plymouth PLA 8AA, UK 
Recent studies have implicated the IL-I gene c;luster in acute pancreatitis, an 
inflammatory condition of the pancreas. A penta-allelic polymorphism is known to 
exist in intron 2 of the IL-lra gene in which there are a variable number of tandem 
repeat umts each 86bp long. In addition, a biallelic polymorphism is present in exon 
5 of the IL- 113 gene which involves a C to T substitution. The aim of this study was 
to investigate these polymorphisms in ::,,ute pancreatitis. The genotype and allele 
frequencies were determined inpatients (n=125) and healthy controls (n=! 50) asmg 
the polymerase chain reaction. Patients were categorised according to aetiology 
(alcohol, idiopathic, gallstone), severity (mild/severe) and organ failure scores 
(OFS->>2, OFS->3, OFS->4). There was an increased frequency of allele I of the IL- 
Ira polymorphism in idiopathics compared to controls (82.4% vs 63%, p<0.01). No 
association was found with any other aetiological group. The frequency of allele 1 
was also significantly increased in severe cases compared to mild cases (81.9% vs 
6g.2%, p<0.05), however, the increase did not correspond to the Organ failure 
scores. 11+-lra may determine severity of acute pancreatitis and susceptibility to 
idiopathic acute pancreatitis. No association was found between IL-i13 and the 
disease. 
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Aminoprocalcitouiu n acute pancrestitis: a better predictor of severity and 
correlates with endotoxaemia, subsequent sepsis and death 
Aramori B J, Becker KL **, Mile P*, Barclay GR***, Snider R.H**, Nylen ES**, 
White JC**, Martin IG. Larvin M, McMahon MJ 
Academic Surgical Unit and *Department of Microbiology, The General Infirmary, 
Leeds, UK. **George Washington University, Washington, DC, USA, ***Blood 
Transfusion Services, The Royal Infirmary, Edinburgh. 
lntroduelion: Early prediction of disease severity in patients with acute pancreatitis 
is important for optimal clinical management. Aminoprocalcitonin ( PCT), a 57 
amino acid peptide, is a sensitive marker of inflammation and infection. AIMS: To 
investigate the role of an assay for serum nPCT as an indicator of severity in 
patients with acute pancreatitis and to relate serum nPCT changes to endotoxaemia, 
sepsis and death. Methods: APACHE-II scores and Serum nPCT and endotoxin 
were determined within 24 hours of admission with acute pancreatitis. C-reactive 
protein (CRP) was measured aily, nPC'I concentration was determined by 
radioimmunoassay. Attacks were classified as mild or severe according to the 
Atlanta criteria. Results: There were 69 patients: 55 mild and 14 severe. Severe 
attacks were associated with significantly greater 24 hours APACHE-It scores 
(median ! ! vs g, p=0.02) and peak CRP concentrations (median 202 vs 98, 
p<0.001) compared with mild attacks, nPCT concentrations on admission were 
significantly greater in severe attacks compared with mild (median 783 vs ! 54, 
/-,=0.016), and in those which developed septic complications, fatal or not, compared 
with other attacks (median 1537 vs 165, p--0.025). By receiver operating 
characteristic analysis, the best cut-off level for predicting severe attacks was 200 
pg/ml, with higher sensitivity and specificity compared with admission APACHE-I I 
of>7 (75% vs 69% and 75*/, vs 45% respectively). A positive correlation was 
observed between admission PCT serum levels and endotoxaemia (r=0.5, 
p<0.001 ). Conclusion: Serum nPCT >200 pg/ml al the time of admission gave a 
better prediction of severe acute pancreatitis compared with APACHE-It scores. 
Interncttioncd Jourmd c)l'Panc'recltolo~v Volume 25, 1999 
236 Abst rac ts  
Cytosolic calcium rise from hyperstimulation or store depletion induces 
vacuolisation and enzyme activation i  mouse pancreatic acinar cells. 
MGT Rarao/'2, JB Ward t':, C Vail/and, dP Neoptolemos I, R Sutton s, OH Petersen ~
Departments of Surgery 1, Physiology 2, and Veterinary Preelinical Sciences j, 
University of Liverpool, Liverpool, UK. 
Background: The intracellular event hat initiates acute pancreatitis is unknown. 
This study tested the hypothesis that acute pancreatitis is triggered by abnormal 
elevations ofacinar flee ionised cytosolic alcium ([Ca27i) 
Methods: Isolated mouse pancreatic acinar cells with or without pre-loading of 
the specific calcium chelator BAPTA were incubated with 10 aM cholecystokinin 
(CCK, for hyperstimulation), 2~M thapsigargin (for calcium store depletion) or. 
neither for 60 minutes. Calcium measurements were performed using fura-2. Image 
analysis of light and electron rmcroscope sections was used to quantify the degree of 
cytoplasmic vacuolisation asa marker of cell damage. Cleavage of the specific 
fluorescent substratr for trypsin, bis(isoleucine-prolme-argiaine) rhodamine 110 
((IPR)z-RI 10), was measured by fluorescence after excitation at 485nm as a marker 
for intraceUular enzyme activation. 
Results: Cholecystokinin a d thapsigargin both induced increases in [Ca2*]i of 
724• nmol/L (mean-+SE.) and 223• nmol/L respectively, and increases in
vacuolisation from 3.0:~-0.31 vacuoles/cell and 1. I-~0.21% cell area (in control 
cells) to 9.9• and 4.3:~-0.34% (CCK) and to 13.8s and 5.5+-0.43% 
(thapsigargm). Preloading with BAPTA sigmficantly attenuated the [CaZ~']i 
increases to 216• nmol/L (CCK) and 47:t-6 umol/L (thaosigargin), and also 
markedly reduced vacuolisation to4.0-'x0.38 vacuoles/cell and 1. li-0.13% (CCK) 
and to 7.4• and 2.0i-0.24% (thapsigargin). In parallel with the appearance of
vacuoles, there was a marked increase in the rate of cleavage of(IPRh-R110. 
Conclusions: These data indicate that abnormal elevations of [CaZ*], trigger 
mtracellular abnormalities characteristic of acute pancreatitis including acmar cell 
vacuolisation and intracellular enzyme activation, and suggest that such elevations in
[CaZ'], may initiate acute pancreatitis. 
Mutations in cationic trypsinogen cause hereditary pancreafitis n patients 
originating in the North East of England 
J.E. Creighton, *R. Lyall, "19.1. Wilson, *,4. Curtis and R.M. Charnley 
Dept. of Hepato=Pancreatico-Biliary Surgery, Freeman Hospital, Newcastle and 
*Dept of Haman Genetics, Northern Region Genetics Service 
Hereditary pancreatitis Off') has been linked to mutations in cationic trypsinogen. 
AG to A transition mutation in exon 3 has been shown to cause the disease in 
families originating from the USA and Italy. This mutation creates a novel 
recognition site for At] IIl, a restriction r Other mutations inexon 2 
have also been found. 
Seven families with l ip have been identified by this unit. DNA was extracted from 
venous blood, and exon 3 of cationic trypsinogen amplified by the polymerase chain 
reaction. The PCR product was digested with Aft Ill and fragments sized by 
agarose gel electrophoresis. Haplotype analysis of the families was tamed out. 
Other exons were also amplified and then sequenced. 
Three of the families carried the mutation i  exon 3. Of these, two carried the same 
haplotype, suggesting a common ancestor. Three of the remaining families 
demonslrated anA to T mutation in exon 2 on sequencing. 
A single mutation i  exon 3 ofcatiomc trypsinogen isa common cause of hereditary 
pancreatitis in patients from the North East of England. Further mutations are being 
found. 
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Trypsinogeu mutations in families with Hereditary Pancreatitis n the UK & 
Ireland 
N Howes, IS Rutherford, ~FMcRonald, z! Ellis, 2D Whitcomb. ~R Mowltfora~ JJP 
Neoptolemos, for the UK and Ireland consortium of EUROPAC 
Dept. of Surgery I & Clinical Genetics 2,Univ. of Liveqxml; Dept of Molecular 
Genetics Women's Hospital Liverpool ], & Dept. of Medicine, Univ. of Pittsburgh ~.
Causative mutations for Hereditary Pancreatitis (liP) have been identified in the 
cationic trypsinogen genes at 7q35, which prevent the auto-inactivation of trypsin 
and autodigestion f the pancreas. The aims of our study were to identify cationic 
trypsinogen mutations inUK and Irish families and identify pbenotype genotypo 
correlations. After pedigree and epidemiological analysis, members of families with 
HP were screened for the published cationic trypsinogen mutations. DNA analysts 
was directed at the R117H mutation, The products wore digested with the 
restriction enzyme Alll I, which recognises the common G:A mutation in liP. In 
families negative for this mutation, the N211 mutation was screened using PCR and 
restriction digestion. 30 families have been referred. We have tested 18 of these for 
the R117H and N211 mutations. 7of the families (N=17) have tested positive for the 
R117H mutation and 6 for the N211(N= 0) mutation, 5 families(N--9) had neitbet 
mutation. Patients with the R117H variant developed symptoms at an earlier age 
(.o=0.03), and suffered more attacks (p=0.07) compared to the N211 variant. These 
early findings are similar to the Midwest Multi-centre Pancreatitis Study Group. 
Our findings also suggest that additional mutations and or genes are responsible for 
causing I-fl a. Stats: Mann Whitney U 
Early experience with laparoscopic pancreatectomy 
Ammori E J, A Vezakis, D Davides, Larvin M, 
Leeds Institute for Minimally Invasive Therapy, The General Infirmary, Leeds, UK 
Introduction: Laparoscopic surgery is associated with a reduction in postoperative 
pain and hospital stay, earlier eturn to normal activity and improved cosmesis. 
However; the laparoscopic approach to pancreatic surgery is still evolving. 
Material and Methods: Between 1993 and 1998, 9 patients underwent 
laparoscopic distal pancreatectomy for endocrine tumours (n=-4), cystadenoma 
(n=3), adenocarcinoma (n= 1) and chronic pancreatitis (n=1). Results: There were 
~ven females and three males. The median age of patients was 62 years (range 
30-83 years). Distal pancreatectomy with splenic preservation was performed in 9 
patients, and enucleation i one patient. The ultrasonic dissectors were utilised and 
facilitated issection. Nonetheless, the procedure was converted to open 
pancreatectomy in two patients. The pancreas was divided with a linear stapler in 8 
patients and with the harmonic scalpel in one. Median operative time was 300 
minutes (range 240-360 minutes). Postoperative pancreatic fistula developed in two 
patients in whom the pancreatic stump was not oversown, and responded to 
radiological and supportive management. There were no postoperative d aths. 
Median postoperative hospital stay was 12 days (range 5-60 days). All 
iaparoscopically, treated patients remain well at a median follow up of 24 months 
(3-36). Conclusion: Laparoscopic panereatectomy is a technically demanding 
procedure, but appears feasible and safe. Oversewing of the divided pancreatic 
stump may reduce the risk of pancreatic fistula. The benefits of the laparoscopic 
approach remain to be demonstrated. 
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Improvements in operative mortality for pancreafico--duodenectomy in the 
west midlands following the e~tablishment of a specialist unit. 
M Manu, SR Bramhall, U Gur, BK Gunson, 1(.1 Le Cornu, AD Mayer, DF Mirza, P 
McMaster, JAC Buckels 
Liver Unit, Queen Elizabeth Hospital, Birmingham 
In a recent West Midlands series of pancreatic resections an operative mortality rate 
of 27% was reported with a 5YSR of 5%. These results and others, have led to the 
establishment of specialist units. This unit was established in 1986 and has seen an 
exponential increase in HPB workload, 
A retrospective r view was performed of all patients who underwent pancreatico- 
duodenectomy forturnouts between January 1987 and June 1998. 
169 pancreatico--duodenectomies wereperformed, the male to female ratio was 
1.65, the mean age was 59 years, with a 30 day mortality of 6% and a complication 
rate of 14%. 41% of patients had pancreatic adenocarcinoma, 25% ampullary, 1I% 
cholangiocarcinoma, 8% neuroendocrine and 5% duodenal adenocarcinoma. One 
and 5 YSR for pancreatic adenocarcinoma and ampullary c.arcinoma were 47% and 
6% and 64% and 6% respectively, 40% of these patients were lymph node and 
resection margin egafve and the one and five YSR in this group was 85% and 0%. 
These results how that referral and concentration f cases to a specialist unit leads 
to a significant improvement inoperative mortality but with very little improvement 
in 5YSR. In the subgroup of patients with early disease one YSR appears to be 
improved but with no effect on five YSR. 
Diagnosis and staging of pancreatic carcinoma: comparison of mangafodipir 
trisodium (MnDPDP) enhanced MRI and spiral CT 
IM King, JRG Bell. J C Ileal),. Z Amin. D Predolac r, A Wotherspoon*, J 
Thompson t 
Departments of Radiology and ~Surgery, Chelsea nd Westminster Hospital, 
Department of *I,-Listopatbology, The Royal Marsden Hospital, London 
Aim: To compare MnDPDP enhanced MR] and spiral CT in the diagnosis and 
staging of pancreatic carcinoma. 
Methods: Nineteen patients with suspected pancreatic carcinoma were evaluated 
with MRI and CT. Unenhanced TI/T2, and Ti images 20 minutes and 24 hours 
following infusion of0.5ml/Kg MnDPDP were obtained at 1.0T. CT was performed 
durmg pancreatic and portal venous phases of enhancement. Scans were 
independently assessed for the presence of a pancreatic mass. Resectability was 
determined by evaluating extraglandular extension, vascular involvement, 
lymphadenopathy, peritoneal spread and hepatic metastases. Imaging and surgical 
findings were then compared. 
Results: Pancreatic adenocarcinoma w s diagnosed histologically in 
15/19(79%) patients. MR/and CT both idendfied 15/15 (100%) turnouts. Clear 
evidence of non-resectability was found in 6/15(40*/,) patients at MR/, who did not 
progress to surgery. CT was equivocal in one of these cases. Nine patients 
progressed tolaparoscopy (n=2) or laparotomy (n=7). Of these 9 patients, 
resectability was correctly assessed in 7(77.8%) on MRI and 6(66.7%) by CT. The 
overall accuracy for resectability was 86.7% for MRJ and 73.3% for CT. Liver 
metastases were confidently identified in 3/15 (20%) patients on both MRI and CT. 
Indeterminate liver lesions on CT in two patients were shown to be benign on MRI. 
Conclusion: MiLl performed better than CT ha assessing turnout resectab/lity and 
evaluating associated liver lesions. There was no difference in tumour detection 
between MRI and CT. 
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Endoscopic ultrasonography (EUS) in staging pancreatobiliary neoplasia 
SA Norton, D Alderson 
Bristol Royal Infirmary 
Introduction Most peripancreatic urnouts have a poor prognosis. Radical surgery 
should be avoided for inoperable turnouts or if significant survival benefit is 
unlikely. Current investigations are limited in identifying resectability and lymph 
node metastases. This study aimed to assess the accuracy of EUS in Iocoregional 
staging of pancreatobiliar3, malignancy compared to existing modalities. 
Patients and Methods 41 patients with confirmed pancreatobiliary malignancy 
were studied. Each underwent EUS in addition to standard pre-operauve imaging 
with trans-abdommal ultrasonography (TUS) and computed tomography (CT). 
Results were compared to surgical and histological staging. 
Results All patients underwent trial dissection, with resection possible in 18/41 
cases, the remainder undergoing palliative bypass. TUS could not visualise 21 
turnouts, so could not be expected to identify vascular invasion. Sensitivity, 
specificity, PPV and NPV of CT in predicting vascular involvement was 35.7% 
(CI 13-65%), 100% (CI 85-100%), 1(CI 0.45-1)and 0.71 (CI 0.52-0.86) 
respectively. The presence of 3 or more of 6 EUS features associated with vascular 
invasion had sensitivity of 80% (CI 44-98%), specificity of 94.4% (CI 73-100%), 
PPV of 0.89 (CI 0.52-1), and NPV of 0.89 (CI 0.67-.0.99). EUS was unhelpful in 
large turnouts which prevented duodenal intubation, or caused isplacement of 
vessels beyond the range of EUS. 
Conclusion EUS can provide more accurate staging of pancreatobiliary turnouts in 
selected cases. Larger studies are required to determine the impact of betl~ staging 
on patient outcome. 
Overexpression of c-erbB-2, c-erbB-3 and cyclinDl and loss of p53, pl6 and 
p2| do not correlate with prognosis in reacted ductal pancreatic ancer 
Kawesha A I. Ghaneh P~, Evans JD ~, Campbell 2,Dawiskiba S J Lemoine NR ~. 
Andr~n-Sandberg ,4 J and Neoptolemos JPJ
Departments of Surgery * and 2Pathology, University of Liverpool, UK; Departments of 
3Pathology and JSurgef'y, Lurid University, Sweden; 41CRF, London LIK 
The pathogenesis of pancreatic cancer has been associated with overexpression f 
certain growth factors and their receptors, activation of proto--oncogenes and 
inactivation of turnout suppressor genes but their role in prognosis i not known. 
The aim of our study was to use immunohistochemistry to study the expression of c- 
erbB-2, c-erbB-3, cyclin DI, p53, p21 and pl6 in paraffin-embedded tissue sections 
and correlate the findings with pathological parameters and survwal. 138 resected 
ductal adenocarcinomas were studied comprising a consecutive s ries of patients 
from Sweden (n=69. median age = 63 years) and an equal number from the United 
Kingdom with similar median age. Median survival following resection was 234 
days in the Swedish cases and 353 days in the British cases (p--~0.03). Results of 
positive staining was as follows: 
Country p53 p21 pi 6 c-erbB-2 c-erbB-3 cyclin DI 
UK 4r 30% 1 ! % 30% 58% 65% 
Sweden 33% 25% 14% 30% 39% 78% 
Frequency distribution of age, gender, differentiation, tumonr size, lymph node 
status, stage or survival was the same in the presence or absence of the genetic 
markers tudied. In conclusion, the genetic markers tudied although of 
considerable importance are of no prognostic value. (Statistics: Chi Squared Test) 
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Tumour suppressor gene therapy in pancreatic cancer 
P Ghaneh z,M Humphreys ~, ~ GreenhalJ, NR Lemome 2, JP Neoptolemos z. 
1Department of Surgery, Royal Liverpool Hospital, Liverpool, UK 
~ICRF Molecular Onco/ogy, Hammersmith Hospital, London, LrK. 
Pancreatic cancers demonstrate high rates of loss of function of the tumour 
suppressor genes p53 and p16 ~'r~4" (70% and 80% respectively). These genes have 
a major role in cell cycle control; promoting GI arrest and p53 dependent 
apoptosis.. The aim of this study was to replace the wild-type (wt) p53 and p16 
genes into pancreatic cancer cells and assess the effects on cell growth rates and to 
evaluate turnout cell killing. Human pancreatic cancer cell lines BxPc3, 
MIAPACA2, Panel, Capan2, ('LOH p53, homoz'ygously deleted/mutated p16) were 
used. Adenovirus was used to transfer either wt p53 or wt p16 alone and in 
combination. Therapeutic gene transfer was confirmed using PCR, rt-PCR, western 
blotting and immunofluorescence. Cell counts were used to plot growth curves. 
FACS analysis .was used to assess cell cycle distribution and apoptosis. DNA 
laddering was used to confirm apoptosis. Transfer of p53 inhibited cell growth by 
78-91%, p16 by 66-83% and in combination the median growth inhibition rate was 
increased. Significant rates ofapoptosis was induced by p16 and p53 transfer 
(p<0.004, p<0.03 respectively) and in combination. Adenovu-al mediated transfer of 
p53 and pt6 alone and in combination resulted in significant growth inhibition and 
cell killing. This indicates a role for turnout suppressor gene therapy in pancreatic 
cancer. 
9 may be better than 3 when it comes go sphincter of Oddi manometry. 
EA Stoner, AJK Pzotrowicz, DF Evans, CC Amley. 
The GI science research unit, The London and St. Bartholomew's school of 
Medicine, London. 
Catheter design for sphincter of Oddi (SO) manometry has not changed in nearly 20 
years. The Lehman (Wilson-Cook, USA) triple lumen perfnsed catheter is the most 
widely used. Pressure measurements are made fi'om two of the three lumens. These 
two lumens open 2 rnm apart in distance and 180 degrees in orientation, atthe distal 
end of the catheter. SO manometry using this catheter sometimes shows differing 
pressure profiles from each channel, making the interpretation f results difficult and 
suggesting sphincter asymmetry. Aims: The ann of this study was to assess 
sphincter asymmetry using a new 9 lumen catheter, designed in conjunction with 
Medi-plus, UK. Results: The new nine lumen catheter has 8 perfused channels 
which open at the same level and are orientated uniformly around 360 degrees. The 
ninth channel is for aspiration_ Three studies have been performed so far in patients 
with suspected SO dysfunction. A station pull through technique was used. All 
three patients had asymmetric sphincter pressure profiles. In two patients it was 
marked, with a 110mmHg pressure difference between the maximum and minimum 
pressures at one station. Conclusion: The SO is asymmetric and the new nine 
lumen catheter is superior in assessing this. 
hTterlmtional Joztrna/ ~?f PaJTcreJtolog3' Uo/ume 25, 1999 
Abstracts 241 
Controls 
NIOOM 
CP (n==lS) 
Normal 
GTT 
cP (n = 8) 
Impaked 
GTT 
IsJel AT 
(n = 11) 
Raised intact and split pro-insulin with insulin deficiency after islet 
autotransplantation 
SA White, C Pollard, AC Burden, HA Clayton, JE Davies~ SM Swifi, CN Hales, AR 
Dennison, NJM London 
Department of General Surgery, Leicester General Hospital, Gwendolen Road, 
Leicester LE5 4PW 
Simultaneous i let autotransplantation (AT) following total pancreatectomy for
chronic pancreatitis (CP) can prevent insulin dependence. In an attempt to explain 
insulin dependence a prospective analysis of the secretion of insulin, intact 
proinsulin IP[), 32/33 split pro-insulin (SPI) as well as C-peptide was performed. 
Overall, I 1 consecutive patients having islet AT were assessed. These were 
compared to patients having CP with either impaired glucose tolerance (n = 6) or 
with normal glucose tolerance (n = 15). Patients with NIDDM and non-diabetic 
patients (controls) without CP were also evaluated. All patients received an oral 
(75 gram) glucose tolerance test (GTT). The results are tabulated below: 
C-pep Gluc, ose 0 Glucose 2 Insultn 30 IPi proof 1" SPI proof*" Ratio: 
porto4 "= mm mmo~ a ht~ rmnol "I" rain proof I IPI:SPI 
663 5.5 
590 >7.8 
~3 4.35 
<7.8 
>11.10 
4 .~ 
304 
138 
387 
3.80 
10.82 
4.20 
6.30 
8.10 
6.76 
1.40 
0.81 
4.67 7.12 10.70 101 :$.55 4.25 1.02 
444 7.91 17.55 144 9.92 30.96 0.31 
"fasting samples. All mean values. 
In conclusion, these results demonstrate insulin deficiency, rinsed intact and very 
high 32/3 3 split pro-insulin in the presence o f  hyperglycacnua despite C-peptide 
levels within the normal range m islet automansplam recipients. Possible 
explanations include islet damage during the isolation process, non-physiological 
revasculansation or porto-systemic overspill o f  islet hormones. 
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Stented cyst gastrostomy for pancreatic pseudocysts 
Sutton CD, White S, Berry DP, Chillistone D, Rees Y, Dennison AR 
Department of Stlrgery, Leicester General Hospital, Gwendolen Road, Leicester 
LE5 4PW 
Background We set out to review a single hepatobiliary surgeons experience of 
endoscopic treatment ofpancreatic pseudocysts. Several methods of endoscopic 
treatment have been described, the technique used in Leicester General Hospital 
consists ors combined endoscopic and ultrasound guided percutaneous placement 
of a double J-stent. 
Method Between March 1994 and May 1998, data was retrospectively collected 
for patients who had undergone endoscopic stenting of a pancreatic pscudocyst.. 
Their case notes were examined and a database constructed. 
Results Over the study period, 20 consecutive patients were identified. All 
patients had undergone a standard technique of combined endoscopic and 
ultrasound guided percutaneoas placement ofdouble J stents, between apancreatic 
pseudocyst and the stomach. No patients were lost to follow up which ranged 
between two months and four years. The age range was between 26 and 84 years. 
14 of the pseudocysts were due to acute pancreatitis and 6 were due to chronic 
pancreatitis. All could be seen to be bulging into the posterior wall of the stomach 
at endoscopy. Operation length ranged between 30 and 95 minutes and hospital 
admission ranged between 2 and 77 days. Only two patients suffered complications 
postoperatively; one being readmitted two weeks following stenting with acute 
cholecystitis, the other suffering aperforated duodenal ulcer three weeks after 
stcnting. There were two failures early in the series, both due to stunt migration, 
these s-tents were of a small size (4.7 Fr). Following this, the stent size was 
increased to at least 7 Fr; no further failures occurred. There was no operative 
mortality for the series. 
Conclusion A combined percutaneous and endoscopic yst-gastrostomy stent is a 
safe and effective treatment for patients with suitably placed pseudocysts. 
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Feasibility and outcome of early enteral nutrition in severe acute pancreatitis. 
J.l Powell, J Murchison, G Hill, S Storey, K Fearon, d Ross & .4t( Sirlwardena 
Introduction Although several small studies have reported a benefit from early 
enteral nutrition (EEN) in acute pancreatitis the scope, safety and benefits of this 
technique remain unresolved issues. We therefore report he results of an intertm 
analysis of a single centre randomised controlled trial of EEN in severe acute 
pancreal~tis, focusing on feasibility, tolerance and complications of EEN. 
Methods 14 patients were allocated to receive EEN via a nasojejunal feeding 
tube placed under radiolog~cal screening. For each individual, caloric requirement 
was determined using the Schofield equation. Values are median (range). 
Results Tube placement was successful in 12 individuals. Duration of 
screemag was 3.0 (0.9-11.9) minutes. The median number of tube dislodgement 
episodes was I (0-3) per person Tubes remained in place for a median of 2 (I-7) 
days. The median number of tube placements was I (I-3) per person. The median 
proportion of daily caloric requirement supplied by nasojejunal feeding was 21% (0-- 
100%). In 3 patients the volume of feed was linfited because ofdeus. One patient 
had probable feed-induced diarrhoea. Normal diet was introduced at a median of 5 
(4-9) days. 
Conclusions Nasojejunal tube placement is feasible but there is a high rate of tube 
dislodgement. EEN cannot provide all the nutritional support requtred in severe 
acute pancreatitis. Our findings are at variance with previous tudies therefore 
jnstifymg continued investigation. 
Endoscopic transgastric drainage of pancreatic pseudocysts and abscesses 
complicating acute pancreatitis 
J Cordova and T Leese 
Department of Surgery, Royal Lancaster Infirmary 
Endoscopic transgastric drainage was introduced at a District General Hospital m 
1995 as a new modality for draining pancreatic pseudocysts and abscesses 
following acute pancreatitis. The technique is employed for mature pseudocysts and 
abscesses with good adherence to the stomach wall on CT scan. It is not used if 
there is sigrtiticant pancreatic necrotic debris when we prefer an open drainage 
technique allowing pancreatic necrosectomy atthe same time. 
Six patients have undergone transgastric drainage for pseudocyst (5) or late abscess 
m the pancreatic bed following pancreatic necrosectomy (1), After initial 
a-ansgastric ptmcau'e of the fluid collection with a need/e papillotomy knife under 
x-ray screening control, we now use an over-the-guidewire technique to insert a 12 
French pigtail catheter. 
Five patients were treated successfully and their stents were remoyed at 3 months 
with repeat CT showing no reformation of the fluid collections, la one patiem, the 
teclmique failed due to inadequate adherence ofa pseudocyst to the stomach walt. 
The cyst was punctured with the needle papillotome but during initial injection of 
contrast the cyst disrupted and an open cystojejunostomy was performed. 
During the same time period, 12 other patients underwent open necrosectomy/ 
abscess drainage following acute pancreatitis and 3 underwent open drainage of 
pseudocysts associated with significant necrotic debris or poor adherence to the 
stomach wall. There were no hospital deaths. 
We feel that endoscopic transgastric drainage of selected pancreatic pseudocysts 
and abscesses i a useful option in the management of these complications. It
avoids laparotomy and allows early hospital discharge. 
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Polymorphism of the IL-IO gene in patients with acute pancreatitis 
g Sargen, AG Demaine, AN K~ngsnorth 
Postgraduate Medical School, Plymouth, I.s 
lnterleukin - ! 0 0L-10) is an important regulatory cytokine which suppresses the 
inflammatory esponse seen in acute panereatitis (AP). Polymorphisms of the IL-10 
gene promoter may influence IL-10 levels so affecting disease susceptibility and 
severity. 
Aim To investigate if3 polymorphisms at positions -I I 17, -854, and -627 in the 
il,-10 promoter region influence susceptibility oand severity of AP. 
Methods The IL-10 locus was amplified by PCR from the DNA of 125 patients 
and 130 controls. Sequence specific oligonucleotide probing (SSOP) was then used 
to detect he 3 biallelic polymorphisms. Allelic and genotype frequencies were 
compared in 2x2 contingency tables using the chi-squared statistic. 
IR~ul~ 36 of 125 patients had severe disease (Atlanta), 18 had an organ failure 
score of > 3. AP was due to alcohol in 21 patients, gallstones in64, and was 
idiopathic in 34. No difference was seen in allelic or genotype frequencies atany of 
the 3 loci between patient groups and conlrols, or patient groups tratified according 
to dimase seventy or aetiology. 
Conclusion IL-10 promoter polymorphisms donot influence disease susceptibility 
or severity in AP. 
United Kingdom and Ireland survey of antibiotic prophylaxis in acute 
pancrea titis. 
dd Powell, E Campbell, CD Johnson* & AK Siriwardena 
University Departments ofSurgery, *Southampton General Hospital & Royal 
Infirmary of Edinburgh. 
Introduction Although trials suggest benefits from the prophylactic use of 
antibiotics insevere acute pancreatitis, the results are inconsistent, giving rise to the 
potential for disparate clinical practice. This study therefore aimed to ascertain 
current practice relating to prophylactic antibiotics inacute pancreatitis. 
Methods A postal questionnaire survey of 1103 members of the Association of 
Surgeons of Great Britain and Ireland was performed. Following exclusion of  
surgeons not treating patients with acute pancreatitis, analysis was carried on 429 
replies. 
Results Respondents treated amedian of 12 patients with acute pancreatitis 
per year. Prophylactic antibiotic therapy is used by 88%. Ofthose using 
prophylactic antibiotics 24% used them in all cases. For surgeons professing 
selective use the indications are: prognostically severe (81%), pancreatic necrosis 
(65%), jaundice (49%) and organ dysfunction (34%). Cephalosporins are 
prescribed in72% of cases, with cefuroxime the most common, Combination 
therapy with metromdazole is used in 48%. Duration of therapy is a median of 5 
days for 87% of respondents. An adverse drug reaction atlributable toprophylactic 
antibiotics was reported by ! I%, 
Conclusions Although therapeutic issues remain, this survey establishes that the 
prescription ofprophylactic antibiotics in acute pancreatitis has become widespread. 
However there does not appear to be a consensus regarding the indications, type 
and duration of antibiotic prophylaxis. 
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Endoscopic ultrasound (EUS) in the diagnosis of pancreatobiliary turnouts 
SA Norton, D Alderson 
Bristol Royal Infirmary 
Method Failure to visualise apancreatobiliary tumour on imaging 
investigations, or difficulty m differentiation of turnout from focal chronic 
pancreatitis (CP) may reduce the chances of identifying a small turnout when 
resectable. The value of EUS in diagnosing such turnouts was assessed in 82 
patients with suspected malignancy. EUS findings were compared to those of other 
investigatio~ and to the final diagnosis. 
Results A final diagnosis of neoplasia was made in 48 cases. Sensitivity of 
EUS in diagnosing tumours was significantly greater than that of transabdominal 
ultrasound (TUS) and computerised tomography (CT) Co<0 0001 and p---0.04 
respectively). The sensitivily and specifi~i~ of EUS in diagnosis of neoplastic 
disease when other investigations were normal was 92.3% and 95% respectively. 
Seven patients had turnouts of 2 cm or less in diameter, visualised by EUS in 7/7, 
TUS in 0/5 and CT in 3/7 cases. EUS was only marginally better than CT, ERCP or 
TUS m differentiation f neoplasia from focal UP. 
Conclusion EUS is more sensitive than TUS or CT in diagnosing 
pancreatobiliary turnouts, particularly when small and can confidently exclude 
significant pathology in other cases. Large studies are required to determine 
whether identifying turnouts at an earlier stage could have an impact on mortality. 
EUS does not reliably distingmsh focal CP from tumottr. 
Serum isoamylase and lipase activities in H IV  positive clinical categorios. 
MJMJ Deenamode, A Poz'mak " & t?.,4 Sherwood 
Departments ofClinical Biochemistry and Sexual Health', King's College Hospital, 
London SE5 9RS 
Increasing numbers of HIV +re patients on nucleoside analogue therapy with 
reported pancreatoxJc side effects will result m increased moniloring of serum 
amylase which remains the cheapest and most widely used test in the UK. The 
patterns of serum total pancreatic amylase and lipasc were investigated in a random 
population of 95 H]V+ve patients, 77 (81%) males, mean age 34 years. The 
population was divided into climcal categor/c~: asymptomatic (A, n=23), 
symptomatic non AIDS 03, n=-49) and AIDS (C, n=23). Comparison of each 
category v~th adult controls (n=16) showed a tendency for lipasc alone to be ~gher 
in category A, p.=0.03 (16 whites, 6 blacks, I other), a tendency for total, pancreatic 
and salivary ty'pe amylase and lipase to be higher in category B (33 whites, 16 
blacks, 2 other) patients, p--0.04, 0.06, 0_07, and 0.03 respectively. Concomitant 
elevated pancreatic amylase and lipasr were not observed in any of the patients. 
Comparison of results between ethnic groups revealed total and salivary type 
amylase to be higfier in the b~ack HIV  +re population, p--O.O02 and O.OOl 
respectively, In addition to ethnic amylasaemia, contribution by salivary type 
amylase due to oral and oesophageal infections should be considered when 
interpreting elevated amylase results. 
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Pancreatic lipase and amylase in fuiminant hepatic failure: an 
immunohistochemical survey. 
MJMJ Deenamode, B Portmann', R Przemioslo', A Rayner" & RA Sherwood 
Department of Ciinical Biochemistry and Institute of Liver Studies" King's College 
Hospital, London 
Pancreatic, salivary amylase, lipase and trypsin have been reported to be present in 
hepatic large bile ducts, septal ducts and peribiliary glands m post mortem normal 
livers. The histological presence of amylase and lipase in fulminant hepatic failure 
and their possible contribution to serum levels were investigated by 
mamunoreactivity of pancreatic amylase and lipase antibodies on 5 native and I graft 
biopsy, 4 hepatectomy and 3 post mortem liver specimens obtained fi-om 11 adult 
patients and accompanied by measurement of serum total pancreatic amylase and 
lipase. Positive immtmoreactivity with monoclonal pancreatic lipase antibody was 
observed in 12 (92%) of the 13 samples. Positivity with monoclonal and polyclonal 
pancreatic amylase antibodies were observed in 2 (15"/,) and 7(54%) liver samples. 
immanoreactivity was generally observed periportally, in surviving parenchyma, 
isolated cells and in regenerating cells. The presence of pancreatic lipase in 
regenerating hepatic ells suggested a possible developmental morphogenesis with 
the pancreas or a role in the regeneration process. Furthermore, cholestasis and 
coinciding elevated serum pancreatic lipase suggested hepatic synthesis, storage or 
impaired clearance of the enzyme. 
Serum isoamylase and lipase acfivitie~ in preterm infants. 
MJMJ Deenamode, RM Nicholf, HR Gamsu" & RA Sherwood 
Department of Clinical Biochemistry and Children Nationwide Neonatal Unit'" 
King's College Hospital, London 
Previous authors have reported that amylase and lipase activities were almost 
undetectable in the newborn infant and that exocrine pancreatic function is 
compromised by intrauterine growth retardation (IUGR). Investigation of possible 
factors influencing exocrme pancreatic function in a group of preterm infants was 
carried out by measurement of serum pancreatic lipase (Sigma Diagnostics, UK), 
total and pancreatic amylase (Roche Mannheim Diagnostics, UK) activities in 70 
preterm neonates aged between 0and 30 days, median birth weight 1193 gm (range 
610 to 1890). 
Serum lipnse and pancreatic amylase was undetectable in i % and 89% of neonates, 
respectively. 47 (67%) neonates had serum lipase in the adult reference range, 
median 25 IU/L (range 16-74). 
Furthermore, 9 (13%) had lipase activities above and 14 (20%) below the adult 
range. No differences were noted comparing inclusion and exclusion of neonates 
fed on raw human milk or IUGR. Selective xocrine pancreatic expression oflipase 
but to a much lesser extent pancreatic amylase would correlate with fat being the 
main source of energy at birth. The possibilities of identifying those infants with 
reduced lipase levels could have implications for enteral nutrition of such babies. 
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Audit of deaths from acute pancreatitis in the south east of Scotland 1995-96: 
Evidence for variation in management? 
Aims and Method: An audit of deaths under surgical care from severe acute 
pancreatitis reported to the Scottish Audit of Surgical Mortality (Edinburgh Office) 
during 1995-96. 
Results: 61 deaths were reported: median age was 70 years (range 31-91) with 
13 patients (21%) under the age of 55 years. The predominant mode of death was 
multiple organ failure (49 patients). The median time from admission to death was 8 
days: 20 patients (33%) died within the first 48 hours. 35 patients were managed in 
specialist units, 14 of whom had been transferred from other umts. In 3 patients, 
delay in transfer was thought o contribute to their death. While pulmonary embolus 
contributed to death in 3 patients, DVT prophylaxis was not used in 29 patients 
(48%). 40 patients (66%) were admitted to the ICU. There were no ICU beds 
available for 3 patients and a decision to limit treatment was made for 8 patients. 
No reason was given for the remaining l0 patients whose ages ranged from 75-89 
years. 
Conclusion: A third of patients dying from acute pancreatitis rapidly develop 
MOF and die within 48 hours ofadmission. Some patients were either not 
transferred to specialist units or were uansferred late; Dv'r  prophylaxis was not 
universal; ICU facilities were withheld from a number of elderly patients. 
Investigation of the effect of hypoxia on matrix metalloproteinase expression in 
pancreatic ancer cell lines 
Williams DM, Griffin JA, Matthews GM Buckels JAC, Bramhall SR. 
Department of Surgery, University of Birmingham 
Tumour growth is Ih-nited by the availability of oxygen and growth beyond a few 
hundred micrometres requires neovascularisation. Access to the systemic 
circulation is required for metastasis. The matrix metalloproteinases (l~vfi~s) play a 
critical role in metastasis and angiogenesis and hypoxia is a potent stimulator of 
angiogenic factors and may increase invasion. 
The aim of this study was to investigate the effects of hypoxia on MW expression in 
three pancreatic (BxPC3, Panel, SUIT-2) and one fibrosarcoma (HT-1080) cell 
lines. Oxygen tensions of 20%, 5%, !% and 0% (5% C02) were investigated. 
MMP expression profiles of all cell lines at all oxygen tensions were determined by 
RT-PCR and the level of mRNA quantified by multiplex PCR. MMP protein levels 
were examined by westeva blotting. Expression and activity of MMPs were 
investigated by zymography and a fluorogenic substrate assay, 
Protein analysis was not sensitive nough to detect differential expression but PCR 
analysis identified several MMPs which were upregulated by hypoxia. The greatest 
upregulation was seen in SUIT-2 cells with Stromelysin 2, M'I'MMtr2 and 
MTMMP4 most affected, MTMMP2 and MTMMP4 mRNA levels showed a 
several hundred fold increase at 1% oxygen. 
In conclusion hypoxic regulation of MMP expression may play an important role in 
angiogenesis and tumour invasion. 
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The evolution of a system specific turnout database 
K Le Cornu, BK Gunson, SR Bramhall, DF M~rza, AD Mayer, P McMaster, JAC 
Buckels 
Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham BI 5 2TH 
The Bristol enquiry led to a requirement that all units return data on operative 
outcome, but the quality of the collected ata is left up to individual units. This unit 
has designed a hepatobiliary database, but guidelines introduced since its inception 
has led to several developments in its design. 
The database has been developed to build a risk stratification model for operative 
patients and a standardised approach to reporting to allow inter-unit comparison. 
Data are collected prospectively in outpatients and from medical, nursing, x-ray and 
clerical staff, by a dedicated atabase ctr-ordmator. 
Data collection started on I/9/97 and 551 patients have been entered, 65 with 
pancreatic adenocarcinoma, 13ampullary carcinoma nd 36 chronic pancreatitis. 37 
patients with cancer underwent resection (30 day mortality =5%) and 21 had a 
palliative bypass (30 day mortality ---9.5%). A further 12 patients had no surgery and 
were entered into clinical trials. Data will be presented on patienl demographics 
and tumour pathology. From l/9/98 additional data will be collected on risk factors 
in patients undergoing surgery which will allow stratification when comparing 
results between umts~ Standardised proforma have been developed for 
histopathological, radiological and operative reporting in pancreatic tumours and are 
being evaluated. 
Accurate data collection is now mandatory and these data could be used to 
disadvantage units. The establishment of a well designed, adequately staffed 
database has allowed the development of a flexible system that can be easily 
modified and allows the collection and analysis of data for inter-umt comparison. 
Neutrophil activation in acute pancreatitis - the "two hit" hypothesis confirmed 
A Steven, C McKay, S Robertson, S Evans, CR Carter, CWlmrie 
Lister Dept of Surgery, Glasgow Royal Infirmary 
Background: Early organ failure is an important source of morbidity and mortality 
in acute pancreatitis and there is evidence that it is mediated by activated 
inflammatory cells. It has been proposed that this process may occur in two stages: 
an initial priming of inflammatory cells followed by a further inflammatory "hit" 
which causes further cell activation, inducing organ damage. 
Methods: Patients with acute pancreatitis who did not have organ failure on 
admission (as defined by Atlanta criteria) had daily sampling of peripheral venous 
blood. Neutrophil activation status was assessed by whole blood 
chemiluminescence. 
Results: On admission to hospital, neutrophils from patients with acute 
pancreatitis had a significantly greater oxidative burst than those from control 
patients whether or not organ failure developed. In the group of patients who 
developed organ failure, there was a significant increase in respiratory burst over 
subsequent days which was not observed in patients without organ failure. 
Conclusion: The development ofearly organ failure in acute pancreatitis 
associated with activation of previously primed neutrophils, uggesting a further 
inflammatory stimulus or "second hit". 
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Recent time trends in England and Wale; in gastric and pancreatic ancer 
mortality 
D F~tzstmmons, C Osmond, SGeorge, CDJohnson 
Pancreatic and Biliary Research Group. University of Southampton 
Aims: Time trend analysis provides an important insight into the evolution of 
aetiological risk factors in dis~.ase. We have examined mortality rates in England 
and Wales over 1950-1994 to observe any age-period-cohort effect on current 
b-ends. 
Materials and methods: Mortality data was collected from the Office of National 
Statistics over the time periods. The age-period-cohort effect was modelled using 
Poisson Error. 
Results: Pancreatic ancer ose from 7.9 per 100,000 to a peak of 12.3 per 100,00 
in the mid 1980s in men. Since then, there has been a slight downwards trend. In 
women, the mortality rate has risen from 6.5 per 100,000 to 12 per 100,000 in the 
late 1980s. Since then, mortality rates have stabilised. In gastric cancer, mortality 
rates have shown a decrease, fiom 37.9 per 100,000 to 19.6 per 100,000 in 1990-94 
(men) and 27.8 per 100,000 in 1950 to 12.2 per 100,000 in 1990-94. Like 
pancreatic cancer, these trends are seen in the older age ~oups. When period and 
cohort effect is modelled, there is a downwards trend seen in pancreatic cancer for 
men and women. In gastric ancer, there is no period effect but a significant cohort 
effect in both sexes (p<0.05). 
Conclusion: The period effect in pancreatic cancer is parallel, but occur later than 
other disease series (e.g. lung cancer) and suggests a possible link with decliumg 
rates of tobacco consumption. In gastric ancer the downwards trend and cohort 
effect in both sexes may possible be explained by changes in prevalence of 
Helicobacter Pylori. 
Minimal access techniques in the management of infected pancreatic necrosis 
R Carter, C J McKay, C Wlmrie 
Lister Department of Upper GI Surgery, Glasgow Royal Infirmary 
Infected pancreatic necrosis traditionally requires initial radical debridement with 
continuous post-operative peritoneal lavage, the majority requiring more than one 
laparotomy. Such surgery in patients with established multi-organ dysfimction is 
associated with a mortality approaching 20%. We describe our initial experience of 
primary percutaneous debridement of pancreatic necrosis and the use of sinus tract 
endoscopy in the management of residual sepsis. 
Methods: Following CT guided access and graduated ilatation, we used an 
operating nephroscope toallow in-igation, suction and piecemeal clearance of the 
necrotic solid material from the abscess cavity. A twin lumen drainage system was 
then inserted to allow continuous post--operative lavage. Subsequent sepsis, was. 
managed by Sinus Tract Endoscopy and further postoperative irrigation- 
Results: All patients had bacteriologically proven retroperitoneai sepsis secondary 
to acute pancreatitis. To date we have managed 7 patients with primary 
percutaneous debridement, and 10 with sinus tract endoscopy, five of whom had 
undergone an initial open procedure. One patient required conversion for 
haemon'hage. Two patients died, one fiom muitiorgan failure, and one from liver 
failure one month after resolution of their sepsis, Three are currently inpatients. All 
but two were managed within the I-[DU. The remainder have been discharged, one 
of whom required late endoscopic drainage of a pseudocyst. 
Conclusion: Our initial results are encouraging, and we are currently undertaking a 
more in-depth appraisal of the technique. 
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